Viveve Medical Inc. (NASDAQ: VIVE) is -39.57% lower on its value in year-to-date trading and has touched a low of $2.43 and a high of $14.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIVE stock was last observed hovering at around $2.63 in the last trading session, with the day’s gains setting it 0.21% off its average median price target of $9.63 for the next 12 months. It is also 73.58% off the consensus price target high of $10.75 offered by 2 analysts, but current levels are 66.59% higher than the price target low of $8.50 for the same period.
Currently trading at $2.84, the stock is -4.13% and -16.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.57 million and changing 7.98% at the moment leaves the stock -39.72% off its SMA200. VIVE registered -47.40% loss for a year compared to 6-month loss of -46.61%. The firm has a 50-day simple moving average (SMA 50) of $3.1210 and a 200-day simple moving average (SMA200) of $4.2185.
The stock witnessed a -12.35% gain in the last 1 month and extending the period to 3 months gives it a -12.62%, and is -5.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.96% over the week and 6.81% over the month.
Viveve Medical Inc. (VIVE) has around 42 employees, a market worth around $30.98M and $5.50M in sales. Distance from 52-week low is 16.87% and -80.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-144.50%).
Viveve Medical Inc. (VIVE) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Viveve Medical Inc. (VIVE) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Viveve Medical Inc. is expected to release its quarterly report on 08/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.51 with sales reaching $1.33M over the same period.The EPS is expected to grow by 95.20% this year, but quarterly earnings will post 10.80% year-over-year. Quarterly sales are estimated to grow 2.00% in year-over-year returns.
Viveve Medical Inc. (VIVE) Top Institutional Holders
12 institutions hold shares in Viveve Medical Inc. (VIVE), with 310 shares held by insiders accounting for 0.00% while institutional investors hold 11.44% of the company’s shares. The shares outstanding are 10.91M, and float is at 7.84M with Short Float at 24.13%. Institutions hold 11.44% of the Float.
The top institutional shareholder in the company is HRT Financial LLC with over 25567.0 shares valued at $0.12 million. The investor’s holdings represent 0.25% of the VIVE Shares outstanding. As of Dec 30, 2020, the second largest holder is Blackrock Inc. with 23321.0 shares valued at $0.11 million to account for 0.23% of the shares outstanding. The other top investors are Vanguard Group, Inc. (The) which holds 15579.0 shares representing 0.15% and valued at over $73221.0, while UBS Group AG holds 0.02% of the shares totaling 2278.0 with a market value of $10706.0.
Viveve Medical Inc. (VIVE) Insider Activity
A total of 0 insider transactions have happened at Viveve Medical Inc. (VIVE) in the last six months, with sales accounting for 0 and purchases happening 0 times.